Cargando…
Abscopal responses in patients with metastatic melanoma involving skin and subcutaneous tissues treated with intralesional IL2 plus BCG
Cutaneous melanoma is relatively common with increasing incidence and significant mortality. While the mainstay of therapy is surgical, patients with stage III and IV disease fare poorer than those with early-stage disease and often benefit from adjuvant therapies. While systemic immunotherapy has c...
Autores principales: | Vidovic, Dejan, Helyer, Lucy Kathryn, Pasternak, Sylvia, Giacomantonio, Carman Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172468/ https://www.ncbi.nlm.nih.gov/pubmed/37182189 http://dx.doi.org/10.3389/fonc.2023.1160269 |
Ejemplares similares
-
Insights into the Molecular Mechanisms Behind Intralesional Immunotherapies for Advanced Melanoma
por: Vidovic, Dejan, et al.
Publicado: (2020) -
Cutaneous Breast Cancer Metastasis Is Effectively Treated With Intralesional Interleukin-2 and Imiquimod: A Case Report and Brief Literature Review
por: Drohan, Ashley, et al.
Publicado: (2022) -
Resolution of Metastatic Subungal Eccrine Porocarcinoma Treated with Intralesional Interleukin-2
por: Drohan, Ashley, et al.
Publicado: (2020) -
Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient
por: Vidovic, Dejan, et al.
Publicado: (2021) -
DNA Methylation Predicts the Response of Triple-Negative Breast Cancers to All-Trans Retinoic Acid
por: Coyle, Krysta Mila, et al.
Publicado: (2018)